Indian diplomacy had been battling for a few weeks to persuade the United States, Japan and Australia to invest in its anti-Covid vaccine production capacities.
At the summit of the Quad which was held on March 12, she won her case.
Thus, New Delhi will be able to establish itself as an essential supplier of vaccines for poor countries and counter the diplomacy of its Chinese rival.
To discover
Test, isolation: the procedure to follow in the event of a suspicion of Covid-19
By deciding to help the Indian pharmaceutical group Biological E to increase its production of doses, the Quad has given a boost to the diplomacy driven by New Delhi since the beginning of the year.
The South Asian giant was already well positioned in this area before the epidemic: its companies like Serum Institute of India and Biological E were among the largest producers of vaccines in the world.
Strengthen ties
Since January 20, India has sold or donated 58 million doses to 71 countries.
40% were delivered to Africa and 30% to South Asia.
For New Delhi, it is about countering the influence of
This article is for subscribers only.
You have 69% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in
